BURLINGAME, Calif., Sept. 6, 2024 /PRNewswire/ -- BrainScan, a revolutionary blood test offered by Apollo Health in collaboration with our partner Neurocode, can reveal the earliest stages of dementia years before symptoms even arise. The test analyzes three biomarkers to assess the risk of Alzheimer’s disease and other neurodegenerative conditions, and it is sensitive enough to replace invasive and expensive spinal taps or PET brain scans. The three biomarkers are:
p-Tau 217 is a biomarker for Alzheimer-related processes. This p-Tau 217 test is sensitive enough to detect Alzheimer’s pathology when you are pre-symptomatic. Used alone, it is 95% accurate in predicting amyloid pathology.
NfL (neurofilament light) is a marker of neuronal damage. It can tell you if there is a problem with your neurons from causes like vascular disease, head trauma, or any neurodegenerative process.
- GFAP (glial fibrillary acidic protein) is an early biomarker for inflammation and repair in the brain.
Why BrainScan is Better Than Other Tests
Not all p-Tau 217 tests are created equal. Apollo Health’s test is highly sensitive and the first p-Tau 217 test widely available for consumers. Results are confidential. Consumers can choose who to share their results with and do not need to fear any negative consequences.BrainScan is also unique because Neurocode, a laboratory specialized in Alzheimer’s disease and brain health testing, has published more external and internal data than any other p-Tau 217 blood test on the market. Neurocode’s p-Tau 217 test approach has proven to be highly sensitive and accurate, leading to earlier diagnosis and treatment.
Unlike with other tests, BrainScan customers are provided with a detailed interpretative report that uncovers their dementia risk. In addition, if their results are out-of-range, customers aren’t on their own when deciding the next best course of action. A nationally certified health coach personally reaches out to review results and offer guidance.
How to Get BrainScan
BrainScan is available for purchase online through Apollo Health at http://getabrainscan.com.
About Apollo Health: Apollo Health is a leading provider of innovative health solutions for cognition that empower individuals to optimize their well-being through personalized nutrition, lifestyle modifications, and cutting-edge research. With a team of world-class experts, Apollo Health™ is revolutionizing the approach to health and helping individuals thrive in all aspects of life.
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-alzheimers-high-sensitivity-p-tau-217-test-replaces-spinal-taps-and-pet-scans-in-47-states-302240166.html
SOURCE Apollo Health
